91ÖÆƬ³§

Published on Market Research Reports® Inc. ()

Home > Global Lifitegrast API Market Research Report 2023

Global Lifitegrast API Market Research Report 2023

Publication ID: 
PB504244423
Publication Date: 
May 4, 2023
Pages: 
89
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Specialty Chemicals [2]
Manufacturing (Chemicals) [3]
Chemicals [4]
Description: 

Lifitegrast is an N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used for treatment of keratoconjunctivitis sicca (dry eye syndrome). It has a role as an anti-inflammatory drug and a lymphocyte function-associated antigen-1 antagonist. It is a L-phenylalanine derivative, a sulfone, a N-acyl-L-alpha-amino acid, a member of isoquinolines and a member of 1-benzofurans.
The global Lifitegrast API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lifitegrast API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lifitegrast API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Lifitegrast API include Dr. Reddy’s Laboratories Ltd., Gentec Pharmaceutical Group, Teva API, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals, Olon Spa and ScinoPharm Taiwan, Ltd, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lifitegrast API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lifitegrast API.
The Lifitegrast API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lifitegrast API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lifitegrast API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Dr. Reddy’s Laboratories Ltd.
Gentec Pharmaceutical Group
Teva API
Sun Pharmaceutical Industries Ltd.
Glenmark Pharmaceuticals
Olon Spa
ScinoPharm Taiwan, Ltd
Segment by Type
±Ê³Ü°ù¾±³Ù²â≥98%
Purity<98%
Segment by Application
Lifitegrast Ophthalmic Solutions
Others
Production by Region
India
Europe
China
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lifitegrast API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lifitegrast API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lifitegrast API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Lifitegrast API Market Overview
1.1 Product Definition
1.2 Lifitegrast API Segment by Type
1.2.1 Global Lifitegrast API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 ±Ê³Ü°ù¾±³Ù²â≥98%
1.2.3 Purity<98%
1.3 Lifitegrast API Segment by Application
1.3.1 Global Lifitegrast API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Lifitegrast Ophthalmic Solutions
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Lifitegrast API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Lifitegrast API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Lifitegrast API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Lifitegrast API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lifitegrast API Production Market Share by Manufacturers (2018-2023)
2.2 Global Lifitegrast API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Lifitegrast API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Lifitegrast API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Lifitegrast API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Lifitegrast API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lifitegrast API, Product Offered and Application
2.8 Global Key Manufacturers of Lifitegrast API, Date of Enter into This Industry
2.9 Lifitegrast API Market Competitive Situation and Trends
2.9.1 Lifitegrast API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lifitegrast API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lifitegrast API Production by Region
3.1 Global Lifitegrast API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Lifitegrast API Production Value by Region (2018-2029)
3.2.1 Global Lifitegrast API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Lifitegrast API by Region (2024-2029)
3.3 Global Lifitegrast API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Lifitegrast API Production by Region (2018-2029)
3.4.1 Global Lifitegrast API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Lifitegrast API by Region (2024-2029)
3.5 Global Lifitegrast API Market Price Analysis by Region (2018-2023)
3.6 Global Lifitegrast API Production and Value, Year-over-Year Growth
3.6.1 India Lifitegrast API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Lifitegrast API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Lifitegrast API Production Value Estimates and Forecasts (2018-2029)
4 Lifitegrast API Consumption by Region
4.1 Global Lifitegrast API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Lifitegrast API Consumption by Region (2018-2029)
4.2.1 Global Lifitegrast API Consumption by Region (2018-2023)
4.2.2 Global Lifitegrast API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Lifitegrast API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Lifitegrast API Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lifitegrast API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Lifitegrast API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lifitegrast API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Lifitegrast API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lifitegrast API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Lifitegrast API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Lifitegrast API Production by Type (2018-2029)
5.1.1 Global Lifitegrast API Production by Type (2018-2023)
5.1.2 Global Lifitegrast API Production by Type (2024-2029)
5.1.3 Global Lifitegrast API Production Market Share by Type (2018-2029)
5.2 Global Lifitegrast API Production Value by Type (2018-2029)
5.2.1 Global Lifitegrast API Production Value by Type (2018-2023)
5.2.2 Global Lifitegrast API Production Value by Type (2024-2029)
5.2.3 Global Lifitegrast API Production Value Market Share by Type (2018-2029)
5.3 Global Lifitegrast API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Lifitegrast API Production by Application (2018-2029)
6.1.1 Global Lifitegrast API Production by Application (2018-2023)
6.1.2 Global Lifitegrast API Production by Application (2024-2029)
6.1.3 Global Lifitegrast API Production Market Share by Application (2018-2029)
6.2 Global Lifitegrast API Production Value by Application (2018-2029)
6.2.1 Global Lifitegrast API Production Value by Application (2018-2023)
6.2.2 Global Lifitegrast API Production Value by Application (2024-2029)
6.2.3 Global Lifitegrast API Production Value Market Share by Application (2018-2029)
6.3 Global Lifitegrast API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Lifitegrast API Corporation Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Lifitegrast API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Ltd. Lifitegrast API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7.2 Gentec Pharmaceutical Group
7.2.1 Gentec Pharmaceutical Group Lifitegrast API Corporation Information
7.2.2 Gentec Pharmaceutical Group Lifitegrast API Product Portfolio
7.2.3 Gentec Pharmaceutical Group Lifitegrast API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Gentec Pharmaceutical Group Main Business and Markets Served
7.2.5 Gentec Pharmaceutical Group Recent Developments/Updates
7.3 Teva API
7.3.1 Teva API Lifitegrast API Corporation Information
7.3.2 Teva API Lifitegrast API Product Portfolio
7.3.3 Teva API Lifitegrast API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Teva API Main Business and Markets Served
7.3.5 Teva API Recent Developments/Updates
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Sun Pharmaceutical Industries Ltd. Lifitegrast API Corporation Information
7.4.2 Sun Pharmaceutical Industries Ltd. Lifitegrast API Product Portfolio
7.4.3 Sun Pharmaceutical Industries Ltd. Lifitegrast API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Lifitegrast API Corporation Information
7.5.2 Glenmark Pharmaceuticals Lifitegrast API Product Portfolio
7.5.3 Glenmark Pharmaceuticals Lifitegrast API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.6 Olon Spa
7.6.1 Olon Spa Lifitegrast API Corporation Information
7.6.2 Olon Spa Lifitegrast API Product Portfolio
7.6.3 Olon Spa Lifitegrast API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Olon Spa Main Business and Markets Served
7.6.5 Olon Spa Recent Developments/Updates
7.7 ScinoPharm Taiwan, Ltd
7.7.1 ScinoPharm Taiwan, Ltd Lifitegrast API Corporation Information
7.7.2 ScinoPharm Taiwan, Ltd Lifitegrast API Product Portfolio
7.7.3 ScinoPharm Taiwan, Ltd Lifitegrast API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 ScinoPharm Taiwan, Ltd Main Business and Markets Served
7.7.5 ScinoPharm Taiwan, Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lifitegrast API Industry Chain Analysis
8.2 Lifitegrast API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lifitegrast API Production Mode & Process
8.4 Lifitegrast API Sales and Marketing
8.4.1 Lifitegrast API Sales Channels
8.4.2 Lifitegrast API Distributors
8.5 Lifitegrast API Customers
9 Lifitegrast API Market Dynamics
9.1 Lifitegrast API Industry Trends
9.2 Lifitegrast API Market Drivers
9.3 Lifitegrast API Market Challenges
9.4 Lifitegrast API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned: 

Dr. Reddy’s Laboratories Ltd.
Gentec Pharmaceutical Group
Teva API
Sun Pharmaceutical Industries Ltd.
Glenmark Pharmaceuticals
Olon Spa
ScinoPharm Taiwan, Ltd

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-lifitegrast-api-market-research-report-2023

Links
[1] /countries/global[2] /specialty-chemicals[3] /manufacturing-chemicals[4] /chemicals